This discrepancy has not yet been explored fully, but it is possible that the environment in which each disease develops (such as the extent and severity of hypoxia) and/or a lack of suitable mitochondrial metabolic plasticity may play a role in determining why IDH2 mutations are not observed often in gliomas. Here, IDH2 is linked to glioma.